Recombinant VEGF (Bevacizumab Biosimilar) anticorps

N° du produit ABIN5668150

Détail du produit anti-VEGF (Bevacizumab Biosimilar) anticorps

Antigène: VEGF (Bevacizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp VEGF (Bevacizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Western Blotting (WB), Blocking Reagent (BR), Immunoprecipitation (IP)

Specificité: This antibody binds native and reduced human VEGF (isoform 165).

Attributs du produit:

OriginalSpeciesName: Human

OriginalFormat: IgG1

Purification: Purified antibody.

Pureté: > 98 % as determined by SDS-PAGE

niveau d'endotoxine: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogène: Recombinant human VEGF.

Isotype: IgG1 kappa

Information d'application

Indications d'application: This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

Commentaires:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Restrictions: For Research Use only

Stockage

Buffer: PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur VEGF (Bevacizumab Biosimilar)

Antigène: VEGF (Bevacizumab Biosimilar)

Abstract: VEGF (Bevacizumab Biosimilar) Produits

Synonymes: anticorps MVCD1, anticorps VEGF, anticorps VPF, anticorps vascular endothelial growth factor A, anticorps VEGFA

Sujet: Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF

UniProt: P15692